[Cholestyramine therapy in type II hyperlipoproteinemia].
D000328:Adult; D000368:Aged; D001796:Blood Protein Disorders / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use*; D003248:Constipation / Q000139:chemically induced; D004415:Dyspepsia / Q000139:chemically induced; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D008074:Lipoproteins; D002792:Cholestyramine Resin; D002784:Cholesterol
Kolestyraminbehandling af type II hyperlipoproteinaemi.